Morgan Stanley’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-86,573
| Closed | -$992K | – | 7709 |
|
|
2020
Q4 | $992K | Buy |
86,573
+82,308
| +1,930% | +$938K | ﹤0.01% | 4673 |
|
|
2020
Q3 | $30K | Sell |
4,265
-122,551
| -97% | -$805K | ﹤0.01% | 5913 |
|
|
2020
Q2 | $827K | Buy |
126,816
+113,033
| +820% | +$730K | ﹤0.01% | 4310 |
|
|
2020
Q1 | $91K | Sell |
13,783
-58,000
| -81% | -$506K | ﹤0.01% | 5225 |
|
|
2019
Q4 | $744K | Buy |
71,783
+60,828
| +555% | +$520K | ﹤0.01% | 4710 |
|
|
2019
Q3 | $69K | Buy |
10,955
+5,023
| +85% | +$37.4K | ﹤0.01% | 5580 |
|
|
2019
Q2 | $44K | Buy |
5,932
+2,412
| +69% | +$15.9K | ﹤0.01% | 5667 |
|
|
2019
Q1 | $22K | Sell |
3,520
-18,831
| -84% | -$218K | ﹤0.01% | 5986 |
|
|
2018
Q4 | $257K | Sell |
22,351
-1,518
| -6% | -$25.9K | ﹤0.01% | 5182 |
|
|
2018
Q3 | $516K | Sell |
23,869
-41,069
| -63% | -$777K | ﹤0.01% | 4983 |
|
|
2018
Q2 | $1.02M | Buy |
64,938
+41,074
| +172% | +$646K | ﹤0.01% | 4621 |
|
|
2018
Q1 | $450K | Buy |
23,864
+1,720
| +8% | +$33.9K | ﹤0.01% | 5067 |
|
|
2017
Q4 | $385K | Sell |
22,144
-19,601
| -47% | -$271K | ﹤0.01% | 5112 |
|
|
2017
Q3 | $625K | Buy |
41,745
+11,841
| +40% | +$186K | ﹤0.01% | 4735 |
|
|
2017
Q2 | $555K | Sell |
29,904
-10,401
| -26% | -$181K | ﹤0.01% | 4734 |
|
|
2017
Q1 | $681K | Buy |
40,305
+5,968
| +17% | +$119K | ﹤0.01% | 4650 |
|
|
2016
Q4 | $731K | Buy |
34,337
+31,579
| +1,145% | +$648K | ﹤0.01% | 4682 |
|
|
2016
Q3 | $50K | Sell |
2,758
-23,360
| -89% | -$527K | ﹤0.01% | 5596 |
|
|
2016
Q2 | $756K | Buy |
+26,118
| New | +$727K | ﹤0.01% | 4177 |
|
Morgan Stanley's ARA Position: Q1 2021 in Review
Morgan Stanley sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 86,573 shares — an estimated $992K sold.
Morgan Stanley first reported a position in ARA in Q2 2016 and held it in 19 quarters. The position peaked at $1.02M in Q2 2018. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- Morgan Stanley reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- Morgan Stanley sold 86,573 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $992K.
- Morgan Stanley first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 19 quarters.
- Morgan Stanley's American Renal Associates Holdings, Inc position peaked at $1.02M in Q2 2018.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.